To view or add a comment, sign in A Rutgers study shows that opioid prescriptions for adolescents and young adults on Medicaid have declined significantly over the last two decades
Different GLP-1 formulations have varying pharmacokinetic profiles as described in their SmPCs: Short-acting agents reach peak concentrations more quickly Long-acting weekly injections (semaglutide, dulaglutide) take 45 weeks to achieve stable blood levels [12] [13] Dose escalation schedules deliberately delay full therapeutic effect to improve tolerability Renal function affects clearance of some agents (particularly exenatide), potentially altering response time [19] [20] Adherence and administration technique critically affect outcomes
doi: 10.3389/fpubh.2026.1750738 Received 20 November 2025 Revised 01 February 2026 Accepted 12 February 2026 Published 24 February 2026 Volume 14 - 2026 Edited by Ploutarchos Tzoulis, University College London, United Kingdom Reviewed by Theocharis Koufakis, Aristotle University of Thessaloniki, Greece Junxian Song, Peking University People's Hospital, China Updates Copyright 2026 Song, He, Cui, Sun, Liu, Yu, Li and Jin
J.GoldringC
In recent years, semaglutide has gained attention not only for its effects on diabetes but also for how it can help people lose weight